featured
TAVI Using the Trilogy Transcatheter Heart Valve in Patients With High-Risk Symptomatic Native Aortic Regurgitation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study
Lancet 2024 Mar 26;[EPub Ahead of Print], TP Vahl, VH Thourani, RR Makkar, N Hamid, OK Khalique, D Daniels, JM McCabe, L Satler, M Russo, W Cheng, I George, G Aldea, B Sheridan, D Kereiakes, H Golwala, F Zahr, S Chetcuti, P Yadav, SK Kodali, H Treede, S Baldus, N Amoroso, LS Ranard, DS Pinto, MB LeonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.